Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Orforglipron Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Novel two-step route for Orforglipron intermediate. High purity, scalable process reduces cost and supply chain risks for pharmaceutical manufacturing.